Clinical Trial Update: Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the combination of cabozantinib and selumetinib for plexiform neurofibromas in Neurofibromatosis type 1, with the study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Plexiform Neurofibroma

Drugs mentioned

• Koselugo (selumetinib)
• cabozantinib (cabozantinib)

Snippet

Sponsor: Girish Dhall, MD | Conditions: Neurofibromatosis 1, Plexiform Neurofibroma | Phase 1 | Status: NOT_YET_RECRUITING